Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study (Q42994755)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 February 2010
edit
Language Label Description Also known as
English
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study
scientific article published on 11 February 2010

    Statements

    Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study (English)
    T Witthoeft
    D Hueppe
    B Moeller
    G Teuber
    S Wollschlaeger
    A Baumgarten
    K-G Simon
    N Dikopoulos
    S Mauss
    11 February 2010
    459-468

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit